MoneyWorks4Me

Everest Organics board approves unaudited financial results

08 Feb 2021 Evaluate

Everest Organics has informed that the Board of Directors of the Company at its meeting held on February 08, 2021, considered and approved the Unaudited Financial Results for the third quarter ended December 31, 2020 and declaration of payment of Interim Dividend for the financial year 2020-21.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..